Nurox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nurox

What is Nurox? An Overview

The following quick facts establish the core identity and foundational purpose of Nurox (Azithromycin).

Property Description
Active Ingredient Azithromycin (INN)
Form Oral tablets, capsules, or suspension (liquid)
Pharmacological Class Macrolide Antibiotic (Azalide subclass)
General Purpose Systemic anti-infective treatment
Origin Semisynthetic

Nurox: Identity and Classification

Nurox is a pharmaceutical preparation available by prescription only, containing the single active ingredient, Azithromycin (INN). Azithromycin is a broad-spectrum antibiotic belonging to the macrolide family. The substance is structurally characterized as an azalide, representing a semisynthetic compound derived from the foundational macrolide, Erythromycin.

The specific formulation of Azithromycin in Nurox possesses a distinct pharmacokinetic profile. This structural modification allows for acid stability and prolonged tissue distribution. This characteristic facilitates its use as a systemic anti-infective for susceptible bacterial illnesses, establishing its role as an antimicrobial agent.

Composition, Forms, and Foundational Action

As a single-ingredient product, Nurox focuses on the therapeutic action of Azithromycin. It is commonly supplied in film-coated tablets, capsules, and an oral suspension—the liquid form being a feature often utilized for specific patient groups. There are also intravenous options for use in clinical settings.

The mechanism by which the active component functions is the inhibition of bacterial protein synthesis. The drug achieves this by binding selectively to the 50S ribosomal subunit within the bacterial cell, which prevents the assembly of proteins necessary for the pathogen to grow and multiply. This process arrests the ability of the bacteria to proliferate, defining the medicine's role as an antimicrobial agent.

Regulatory References

  1. StatPearls - NIH

What side effects are possible with Nurox?

Possible Side Effects and Safety Information

The safety profile for Nurox (Azithromycin) is classified by regulatory authorities based on the frequency and system-organ class of documented adverse reactions. The most commonly reported effects are generally those affecting the gastrointestinal system, including diarrhea, nausea, abdominal pain, and vomiting. Headache is also frequently listed in regulatory documents.


Serious Systemic Safety Considerations

Official labeling highlights the potential for several rare, yet serious, adverse reactions. These include potentially life-threatening outcomes such as Fatal Hepatic Injury (liver failure/necrosis) and serious, documented effects on heart rhythm like QT prolongation and Torsades de pointes. Severe hypersensitivity reactions, including Anaphylaxis and dermatological conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also documented. Additionally, Azithromycin use is associated with the risk of Clostridioides difficile-Associated Diarrhea (CDAD), which may occur even months after the treatment period has concluded.


Population and Safety Constraints

Regulatory documents specify safety considerations for special populations. Individuals with a known history of QT interval prolongation, those who are older adults (due to increased cardiac risk), and patients with severe hepatic or renal impairment require particular caution. It is formally restricted in individuals with a known history of hypersensitivity to Azithromycin or other macrolides. The label also contains notes regarding the potential exacerbation of Myasthenia Gravis and, in neonates, the risk of Infantile Hypertrophic Pyloric Stenosis (IHPS).

Overdose and Emergency Response

Overdose and When to Seek Help

Official government regulatory bodies specify the documented manifestations and required emergency actions in the event of an overdose with Nurox (Azithromycin).


Documented Overdose Presentations

Overdose manifestations are primarily described as an exaggeration of known side effects.

System Documented Symptoms / Outcomes
Gastrointestinal Nausea, vomiting, and diarrhea
Cardiovascular Risk of QT interval prolongation and potentially life-threatening cardiac arrhythmias, including Torsades de Pointes

Required Emergency Actions

The regulatory profile for Azithromycin requires specific actions to be taken in an overdose situation:

  • Seek immediate medical attention. This instruction is mandatory upon suspicion of overdose.
  • Urgent medical evaluation is specifically required if symptoms of serious cardiac events occur, such as an irregular heartbeat, shortness of breath, dizziness, or fainting.

Management is supportive and symptomatic as no specific antidote is listed in the official prescribing information. In cases of severe renal impairment, there is a documented increase in systemic exposure, indicating a higher potential for dose-dependent toxicity.

Therapeutic Uses of Nurox

What Nurox Treats: Main Uses and Benefits

Nurox (Azithromycin) is generally used as an anti-infective for managing mild to moderate bacterial infections, providing supportive relief across several key therapeutic domains. The primary therapeutic benefit is that it supports patients during episodes of heightened discomfort and contributes to easing the overall symptom load during symptomatic periods. This medication is commonly used across conditions presenting with acute episodes, including community-acquired pneumonia, acute bacterial sinusitis, acute otitis media, uncomplicated skin infections, and certain sexually transmitted infections (STIs).


Key Therapeutic Focus

Nurox is applied in clinical settings that involve acute or unstable symptom patterns, and is used for managing symptom clusters that create noticeable physiological strain, such as cough, difficulty breathing, facial pressure, or genital discharge. It is relevant when supportive symptom management is appropriate during acute bacterial exacerbations of chronic bronchitis, and it may be part of symptomatic management for long-term support in high-risk patients.

“This medication is applied across domains where additional symptomatic support is needed, and is relevant for managing symptoms that interfere with daily comfort.”


Quick Fact: Symptom Support Focus
Nurox supports patients during episodes of heightened discomfort by addressing symptoms related to inflammatory or irritative states, which may assist with maintaining functional stability.

Regulatory References

  1. NIH DailyMed official drug label for Azithromycin

Eligibility and Restrictions for Use

Who Can and Cannot Use Nurox? Official Regulatory Information

Eligibility to use Nurox (Azithromycin) is determined by strict population-based rules and contraindications defined in government regulatory documents.


Contraindicated Populations

Nurox is strictly contraindicated in patients with a known history of hypersensitivity (allergic reaction) to azithromycin, erythromycin, or any macrolide/ketolide antibiotic. Use is also prohibited for patients with a documented history of cholestatic jaundice or hepatic dysfunction associated with previous azithromycin therapy.


Age and Comorbidity Restrictions

Eligibility Group Restriction Status (Official Labeling)
Infants (< 6 months) Use not established for most standard indications.
Severe Hepatic Impairment Not recommended or use with extreme caution.
Severe Renal Impairment Use requires caution ( GFR < 10 mL/min).
Cardiovascular Risk Use requires caution in patients with a prolonged QT interval or uncorrected hypokalemia/hypomagnesemia.

Physiological State Limitations

Nurox should be used during pregnancy only if clearly needed, as the safety of the drug has not been fully confirmed in this population. For lactation, Nurox is excreted in breast milk, and regulatory guidance requires a decision on whether to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nurox (Azithromycin) has officially documented interaction patterns that restrict co-administration with specific medicinal products and require mandatory timing separation with certain compounds. This information is consistent with regulatory labels from government health authorities.


Formal Restrictions and Contraindications

Co-administration is strictly prohibited with certain substances due to the risk of severe outcomes, which are formally designated as contraindications in regulatory prescribing information:

  • Pimozide: Prohibited due to the potential for Azithromycin to increase Pimozide concentration, which carries a risk of QT interval prolongation.
  • Ergotamine and Dihydroergotamine: Co-administration is prohibited due to the risk of acute ergotism.

Pharmacodynamic and Exposure-Altering Interactions

Interaction Type Interacting Substance/Class Official Regulatory Statement
Pharmacodynamic Risk QTc-Prolonging Drugs Use restricted due to potential for additive QTc prolongation effects.
Exposure Increase Nelfinavir Co-administration increases Azithromycin's maximum plasma concentration ( C max) and overall exposure ( AUC) by approximately 50%.
Transporter Effect P-glycoprotein (P-gp) Substrates Azithromycin is an official P-gp inhibitor, which may alter the exposure of co-administered P-gp substrate medicines.
Timing Requirement Aluminum/Magnesium Antacids Must be administered at least 2 hours apart from Azithromycin to ensure proper absorption.

Interaction classifications may vary by region; this information focuses on the core constraints outlined in major regulatory documents. Caution is also noted for patients with hepatic impairment and elderly patients, who may experience altered clearance or increased sensitivity to QTc effects.

Mechanism of Action

How Nurox Works

Nurox (Azithromycin) exerts its primary pharmacodynamic effect by blocking the microbial protein synthesis pathway. The molecule achieves this by targeting the bacterial 50S ribosomal subunit, the key machinery for generating essential proteins. Specifically, Azithromycin binds to the 23S ribosomal RNA component at the peptidyl transferase center, acting as a blocker of ribosomal translocation. This interference prevents the elongation of the growing peptide chain, which arrests microbial proliferation and results in a bacteriostatic physiological state of reduced microbial population density.

A distinct secondary mechanism involves the modulation of host inflammatory signals. Azithromycin accumulates within host immune cells, such as macrophages, and influences intracellular signaling pathways. This action leads to the reduced production and subsequent release of several pro-inflammatory cytokines, producing an attenuation of localized inflammation by reducing the impact of excessive inflammatory mediator activity.

Mechanistic effectiveness is constrained by microbial evasion strategies, including the genetic modification of the ribosomal target site or the activation of efflux pump systems that rapidly expel the drug, leading to the failure of the protein synthesis inhibition mechanism.

Dosage and Administration Information

Nurox (Azithromycin) administration follows specific parameters detailing the route, dose, and frequency. The medicine is available for both oral intake (as tablets, capsules, or suspension) and intravenous (IV) infusion, with intramuscular injection specifically not approved.


Standard Administration Patterns

Use Principle Details
Oral Dosing Frequency Typically once daily for multi-day regimens.
Standard Adult Course A common course is 500 mg on Day 1, followed by 250 mg once daily for Days 2–5.
Timing with Food Oral formulations may be taken with or without food.
Course Duration Most standard treatments are administered over 3 to 5 days, or as a single 1,000 mg dose for certain indications.

Intravenous Use and Preparation

The intravenous route is generally reserved for initial therapy in specific clinical settings. IV Azithromycin must be prepared by reconstitution and subsequent dilution to a specific concentration prior to administration. The solution must be administered as a slow, controlled infusion lasting for 60 minutes or longer; rapid bolus injection is procedurally prohibited.

Population-Specific Guidance

Standard guidance exists regarding usage in specific populations. For patients with mild-to-moderate renal impairment, no formal dosage adjustment is required. For missed doses, the instruction is to take the dose immediately and resume the usual once-daily schedule thereafter.

Recent Clinical Evidence

Nurox: Recent Clinical Evidence

Evidence for Use in Acute Respiratory and Skin Infections

Research has extensively examined the use of the active ingredient Azithromycin for conditions characterized by episodic or acute changes, such as community-acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis. These studies were conducted during periods of increased symptom activity and typically monitored outcomes related to physical discomfort and systemic imbalance.

Some trials reported measurements of similar short-term outcomes when the active ingredient was compared to alternative antibiotic regimens. Observational studies, which do not establish cause and effect, associated the use of regimens containing the active ingredient with measurements related to 30- and 90-day mortality. Follow-up durations were limited in many of the key comparative trials, providing restricted insight into potential long-term impacts.

Long-Term Studies and Follow-up in Chronic Conditions

A distinct body of research was evaluated in patients with Chronic Obstructive Pulmonary Disease (COPD), focusing on the prevention of episodes where symptoms become more noticeable. This evidence comes from large, long-term Placebo-Controlled Randomized Controlled Trials (RCTs) where patients were observed in a maintenance therapy setting.

The long-term studies report patterns describing how symptoms evolved in the observed populations, noting that the treatment group's time between exacerbation events was longer and the measured rate of these events was lower over the study period. However, this research also reported changes measured during the study period that included certain measured risks. Studies monitored the emergence of antimicrobial resistance and reports of specific non-infectious adverse events, such as hearing impairment, where data show patterns related to an increased incidence in the treatment group.

Consistency, Research Gaps, and Areas of Scientific Uncertainty

The research conducted so far contributes to the broader evidence landscape, yet certain limitations exist. The primary area of uncertainty lies in that long-term effects are not fully established, particularly concerning the non-infectious risks and the overall impact of sustained use on antimicrobial resistance. These research limitations mean that the findings describe group patterns, not personal outcomes, and the research only helps show what has been observed so far.

Key Studies & References

  1. Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Nurox (FAQ)

Q: Does Nurox cause weight changes?

A: Regulatory documents do not commonly list general weight gain or loss as a standard side effect. However, official safety information notes that loss of appetite may be associated with certain adverse events, and a lack of weight gain in neonates is a symptom documented in connection with the rare pediatric condition, Infantile Hypertrophic Pyloric Stenosis (IHPS).

Q: Is Nurox meant to be taken long-term or short-term?

A: Official information describes standard treatment courses for acute conditions lasting approximately three to five days. However, the active ingredient has been examined in long-term clinical trial settings for certain chronic conditions.

Q: Can Nurox be taken with common over-the-counter pain relievers?

A: Official information does not list common over-the-counter pain relievers, such as ibuprofen or acetaminophen, as formal contraindications. Official safety information recommends caution for patients with pre-existing risk factors affecting the heart, liver, or kidneys.

Q: Are there any specific foods or drinks that should be avoided while using Nurox?

A: Regulatory information states that Azithromycin can generally be taken with or without food. However, official documents require a minimum separation of two hours between the administration of Azithromycin and antacids that contain aluminum or magnesium to ensure the medication is properly absorbed.

Q: Is Nurox known to cause drowsiness or fatigue?

A: Regulatory documents list fatigue, somnolence (drowsiness), and dizziness as reported adverse reactions that may affect the nervous system. These effects are listed as reported adverse reactions in official safety documents.

Q: Is it normal to feel slightly dizzy when first starting Nurox?

A: Dizziness is documented as an adverse reaction in regulatory safety information. Official guidance highlights this risk, especially for individuals with pre-existing heart conditions.

Q: Why do doctors prescribe Nurox for [Condition A] but sometimes for [Condition B]?

A: Official regulatory documents define the range of approved conditions, often focusing on common bacterial infections such as community-acquired pneumonia and acute exacerbations of chronic bronchitis. The official use is based on the specific conditions for which the drug has received regulatory approval.

Q: Can people who are allergic to certain antibiotics use Nurox?

A: Regulatory information specifies that Nurox is formally contraindicated only in patients with a history of hypersensitivity (allergic reaction) to Azithromycin or to any other antibiotic classified as a macrolide or ketolide.

Q: Does taking Nurox affect blood pressure readings?

A: Official safety warnings focus on the drug's potential to prolong the QT interval, which is an electrical activity change in the heart. Official guidance highlights the need for caution, particularly for individuals with pre-existing cardiac risk factors.

Q: Can Nurox be used by older adults (e.g., over 65)?

A: Official documents highlight that use in older adults is associated with an increased risk of QTc prolongation, necessitating consideration of these factors. There is also a potential for altered drug clearance in this population.

Q: Does Nurox have to be taken at a specific time of day?

A: The standard prescribed regimen for multi-day treatment is typically once daily. This is the only frequency instruction mentioned in official documents, with no required specific time of day noted.

Q: Is there a generic version of Nurox available?

A: The active ingredient in Nurox is Azithromycin. Regulatory documents refer to Azithromycin by its generic name, and it is available as a generic preparation.

Q: Do I need to get regular blood tests while I am taking Nurox?

A: Regulatory safety information highlights the risk of liver injury associated with the drug. For certain patient groups or in specific situations, regulatory documents may recommend particular lab monitoring, such as checking liver function.

Q: Can Nurox affect my sleep patterns?

A: Official safety information lists somnolence, which is a medical term for drowsiness, as an adverse reaction that may affect the nervous system.

Q: Is Nurox safe for children?

A: Official documents state that the safety and effectiveness of use are not established for infants under six months of age. For neonates, regulatory information contains a documented risk of Infantile Hypertrophic Pyloric Stenosis (IHPS).

Q: Does the effectiveness of Nurox decrease over time?

A: Official labeling includes a warning regarding the development of drug-resistant bacteria. The warning notes that use in the absence of a confirmed bacterial infection increases this risk, which reduces the drug's future effectiveness for treating actual infections.

Q: How long does Nurox stay in your system after stopping it?

A: Official documents describe Azithromycin's pharmacokinetic profile, which is the movement of the drug in the body. This profile is noted for its prolonged tissue distribution and long half-life, which enables a once-daily dosing regimen and means the drug persists in the body.

Q: Can Nurox make me more sensitive to the sun?

A: Photosensitivity, which is an increased sensitivity to sunlight that can result in an exaggerated sunburn, is listed as a reported adverse reaction in official safety documents.

Q: Does Nurox interact with birth control pills?

A: Official drug interaction information notes a potential for Azithromycin to reduce the effects of estrogen-containing medications. This potential interaction includes some types of oral contraceptives.

Q: Are there different strengths or formulations of Nurox?

A: Yes, Nurox is available in different formulations, including oral tablets, capsules, and a liquid suspension, as well as an intravenous preparation for clinical use. Dosing regimens noted in regulatory documents include 250 mg, 500 mg, and 1,000 mg equivalents.

Q: What are the rules about driving or operating machinery while taking Nurox?

A: While there is no formal directive, regulatory documents list nervous system side effects such as dizziness and somnolence (drowsiness). These effects may potentially impact the ability to safely operate machinery.

Q: Is Nurox addictive or habit-forming?

A: Regulatory documents do not contain any warnings or statements classifying Azithromycin as an addictive or habit-forming substance.

Q: Does Nurox interact with common psychiatric medications?

A: Official documents list the antipsychotic Pimozide as a formal contraindication due to the risk of QTc prolongation, which is a consideration for other QTc-prolonging medicines.

Q: Why is it important to check drug interactions with Nurox?

A: Official regulatory information mandates checking interactions because the drug is associated with serious pharmacodynamic risks. These risks include the potential for fatal heart rhythm changes (QT prolongation) and severe outcomes like acute ergotism when combined with certain co-administered drugs.

Q: Does Nurox have any effect on appetite?

A: Loss of appetite is documented in safety information as a possible symptom associated with liver injury or other adverse events. Gastrointestinal adverse effects are common with the drug.

Q: Is there a risk of withdrawal symptoms when stopping Nurox?

A: Regulatory documents do not contain warnings or statements regarding a risk of physical withdrawal symptoms upon discontinuation of Azithromycin.

Q: What are the main goals of treatment with Nurox?

A: The general purpose of treatment is to act as a systemic anti-infective by inhibiting bacterial protein synthesis, which arrests microbial proliferation. The drug's mechanism of action also includes the attenuation (reduction) of localized inflammation in the body.

Q: What is the general safety classification of Nurox (e.g., high-risk vs. low-risk)?

A: Official safety documents describe the drug’s profile as commonly resulting in mild gastrointestinal effects. However, the documentation also highlights the potential for rare but serious adverse reactions, which include hepatic injury and cardiac risks.

Q: What is the difference between the 'on-label' use and how some people use Nurox?

A: The 'on-label' use is defined by the specific bacterial infections and conditions for which the drug has received regulatory approval from government health authorities. Official labeling focuses on the conditions supported by formal regulatory review.

How should Nurox be stored and disposed of?

How to Store and Dispose of Nurox?

Regulatory documents define specific storage and disposal requirements for Azithromycin (Nurox) to ensure product stability and safety. The tablets must be stored at controlled room temperature (15 C to 30 C) in a tightly closed container, away from excess heat and moisture. All formulations are subject to a Do Not Freeze restriction, and the constituted oral suspension should not be refrigerated.

Stability and Child Safety

The mixed liquid suspension has a 10-day stability limit and any portion remaining after the full treatment course must be discarded. The medication must always be stored out of the sight and reach of children.

Official Disposal Instructions

Unused or expired medicine should be returned through a formal drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (e.g., dirt) in a sealed bag before placing it in household trash. Do not flush Azithromycin down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nurox found in:

A-Z Index: